MDC
Medlab Clinical Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
4
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. The firm is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.
📈 Performance
Price History
-78.00%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$6.60
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in MDC
4
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in MDC
888 days
MDC investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
50%
Less than 50k
50%
👶 Age of investors
18 - 25
25%
26 - 34
25%
35 - 90
50%
🙋 Legal gender of investors
Female
75%
Male
25%
Pearlers who invest in MDC also invest in...
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
📊 Share price
$320.13 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. The company is headquartered in Perth, Western Australia. The company went IPO on 2014-08-12. The firm is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes CelGro, Striate+, Remplir, and SmrtGraft. CelGro is a collagen medical device that facilitates tissue reconstruction and healing in a variety of dental and orthopedic reconstructive applications. CelGro is manufactured using a SMRT manufacturing process to preserve the natural collagen structure. Striate+ is used for dental GBR applications. Remplir is for peripheral nerve reconstruction. SmrtGraft is for tendon repair. Its other major products are autologous cell therapy, which focuses on regenerating damaged tendon and cartilage tissue. The company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.
📊 Share price
$0.37 AUD
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
📊 Share price
$120.79 AUD
NULL AUSTRALIA
NULL BETA
Qantas Airways Ltd. provides air transportation services. The company is headquartered in Mascot, New South Wales. The firm is focused on the operation of international and domestic air transportation services, the provision of freight services, and the operation of a frequent flyer loyalty program. The firm's segments include Qantas Domestic, Qantas International, Jetstar Group and Qantas Loyalty. The Qantas Domestic, Qantas International, and Jetstar Group are engaged in passenger flying business and air cargo and express freight businesses. The Qantas Loyalty segment is engaged in the customer loyalty recognition programs. Its main business is the transportation of customers using two airline brands, which include Qantas and Jetstar. Its airline brands operate in regional, domestic and international services. The firm operates in Australia, New Zealand, South Pacific, Asia, Europe, North and South America, and Africa.
📊 Share price
$6.51 AUD
NULL AIRLINES
Want more shares? Try these...
Middle Island Resources Ltd. engages in the acquisition, exploration and development of gold deposits. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-16. The firm operates through two segments: Australia and West Africa. The Company’s Barkly Copper-Gold Super Project comprises of 14 exploration licenses granted and two pending applications, which covers approximately 5,510 square kilometers (km2) within the Barkly region of the Northern Territory (NT).
📊 Share price
$0.04 AUD
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The Company’s segments include Australia, the United States, the United Kingdom and Asia Operations. Its product suite is built upon a medication data platform that supports a patient app, a pharmacy-based module PlusOne, and digital health programs, all of which are connected to dispensing networks. The company provides one-tap access to the details of the pharmacy, including phone number, email, opening hours and show-on-map/navigation. The Company’s subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.
📊 Share price
$0.24 AUD
Mariner Corp. Ltd. engages in investment activities and corporate actions. The company is headquartered in North Sydney, New South Wales. The firm is engaged in investment activities and corporate actions. The firm operates across two geographical segments being Australia and Hong Kong. Its investment portfolio comprises quoted equity investments and fixed and variable interest loans, and investments in other schemes. The firm makes strategic investments in listed companies and unlisted companies. The company is also focused on identifying and implementing business opportunities in the market. The Company’s subsidiaries include Mariner Asset Management Limited, Mariner Investments Limited, and Mariner International Limited.
📊 Share price
$0.03 AUD
Mercury NZ Ltd. engages in the generation and distribution of electricity from hydro, geothermal, and gas. The firm generates electricity from renewable resources, such as hydro, geothermal and wind. Its products and services consist of generation/wholesale and retail. Generation/wholesale market segment encompasses activity associated with electricity generation, electricity trading, generation development activities. The company is engaged in sale of electricity to both commercial and industrial customers and the retail segment. Retail segment encompasses activity associated with sale of energy, and related services, to customers in New Zealand. The retail operations serve commercial and residential (small medium sized businesses) customers. The company offers pre-pay electricity product, GLOBUG. The company manages several subsidiary enterprises, such as its EV Subscription Service. The firm is also engaged in the business of gas, telecommunications business, and retail electricity supply business.
📊 Share price